Catalyst Wire Dossier Catalyst Wire Dossier

Burotam

· Yung Shin Pharm. Ind. Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Burotam, covering 2023-02-01 to 2023-02-01. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate Bioequivalence of Burotam (1/1 g/Vial) [Phase 4]

See pricing